Income taxes |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Income Tax Disclosure [Abstract] | |
| Income taxes | 13. Income taxes For the three months ended June 30, 2026 and 2025, the Company recorded consolidated income tax expense from continuing operations of $4.1 million and income tax benefit of $3.9 million, respectively, which represent effective tax rates of 7.8% and 0.8%, respectively. For the six months ended June 30, 2026 and 2025, the Company recorded consolidated income tax expense from continuing operations of $5.5 million and $21.1 million, respectively, which represent effective tax rates of 5.1% and (5.3)%, respectively. The Company’s income tax expense and effective tax rate can fluctuate period to period based on the levels of net income before income taxes, the mix of profits earned in various tax jurisdictions with differing statutory tax rates, the magnitude of non-deductible items and tax credits, changes in valuation allowances, and the impact of discrete items. The income tax expense for the three and six months ended June 30, 2026 primarily consisted of income tax expense in non-U.S. jurisdictions, as federal and state net operating loss carryforwards and stock-based compensation deductions reduced U.S. taxable income. Income tax expense for the six months ended June 30, 2026 also included discrete tax expense items recognized in the first quarter of 2026, including certain prior-period tax adjustments. The Company continues to maintain a valuation allowance against certain U.S. deferred tax assets
|